Select Page

Ketesse injection

Marketed by Ferron Par Pharmaceuticals

Product packaging may vary from one country to another.

Ingredients in every ml

Dexketoprofen 25 mg

Each package contains

5 ampoules of 2 ml

Other details

Dosage form:Injection
Flavour None

W.H.O. classification

ATC Level 1 N - Nervous system
ATC Level 2 N02 - Analgesics
ATC Level 3 N02B - Other Analgesics and Antipyretics in ATC

Warnings

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Alcohol

CAUTIONThis item may not be safe for use with alcohol. Use with caution and after consultation with your doctor.

Machinery

NOT RECOMMENDEDThis item should not be used while operating heavy machinery.

Available in

Indonesia

Dosage information

UP TO 18 YEARS
The safety and efficacy Ketesse in children have not been established and the product should not be used in children.

Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period

18 YEARS OLD AND ABOVE
The recommended dose is 50 mg every 8-12 hours. Repeated every 6 hours if necessary. Total daily dose should not exceed 150 mg.

Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period

POSTOPERATIVE PAIN
Ketesse® can be used with opioid analgesic to overcome the pain, especially in the initial period after surgery when the pain is more painful.

Indication

Symptomatic treatment of acute pain, when oral administration is not appropriate such as postoperative pain. (IPHA p.2, Medscape p.1, PI Ketesse, Product Monograph-2 p.70, Product Profile Injection p.89, SPC p.1)